Teladoc Health (NYSE:TDOC – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.
Profitability
This table compares Teladoc Health and Aclarion’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Teladoc Health | -6.81% | -11.45% | -5.54% |
| Aclarion | -10,320.51% | -54.41% | -51.71% |
Insider and Institutional Ownership
76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 7.5% of Aclarion shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 0.0% of Aclarion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Teladoc Health | $2.51 billion | 0.52 | -$200.32 million | ($0.97) | -7.51 |
| Aclarion | $80,000.00 | 108.55 | -$7.23 million | ($9.03) | -0.39 |
Aclarion has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Comparatively, Aclarion has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and price targets for Teladoc Health and Aclarion, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Teladoc Health | 1 | 11 | 5 | 0 | 2.24 |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
Teladoc Health presently has a consensus price target of $7.43, suggesting a potential upside of 2.02%. Aclarion has a consensus price target of $7.50, suggesting a potential upside of 112.46%. Given Aclarion’s higher possible upside, analysts clearly believe Aclarion is more favorable than Teladoc Health.
Summary
Teladoc Health beats Aclarion on 10 of the 14 factors compared between the two stocks.
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
